SMITH SCOTT THOMAS Insider Trades

Insider Trading History

Track insider trading activity for SMITH SCOTT THOMAS. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $1.16M 4,367 shares
Last Trade
Jun 02, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.9k 100 shares
$219.00
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $1.13M 4,267 shares
Last Trade
May 29, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$55.8k 250 shares
$223.32
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$6.14M 27,000 shares
$227.41
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$5.17M 22,755 shares
$227.41
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$2.17M 9,552 shares
$227.41
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$10.2M 45,000 shares
$227.41
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$3.3M 14,504 shares
$227.41
$265.57
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$10.2M 45,000 shares
$227.41
$265.57

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up